Greenleaf Trust Portfolio holdings
Greenleaf Trust is a privately held, trust-only bank that manages wealth and administers trusts for families. Bill Johnston started it in 1998 after national banks had swallowed up many regional and community banks, wanting a locally owned firm with fiduciary expertise that would serve families across generations. Johnston had already launched a sister firm, Greenleaf Asset Management, in 1991, and the two merged in 2002. The bank builds portfolios around what matters most to each client, whether personal, family-focused or charitable, and avoids selling its own proprietary products. It opened a separate bank, Greenleaf Trust Delaware, in 2018.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$52.8M |
| 2 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$12.7M |
| 3 |
iShares Core S&P Small-Cap ETF
IJR
|
+$10.9M |
| 4 |
Steelcase
SCS
|
+$6.63M |
| 5 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$5.41M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Stryker
SYK
|
+$105M |
| 2 |
Ansys
ANSS
|
+$11.4M |
| 3 |
Merck
MRK
|
+$8.22M |
| 4 |
Procter & Gamble
PG
|
+$6.14M |
| 5 |
American Electric Power
AEP
|
+$5.34M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 78.69% |
| 2 | Miscellaneous | 11.68% |
| 3 | Financials | 2.14% |
| 4 | Technology | 1.8% |
| 5 | Consumer Staples | 1.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Stryker
SYK
$124B
| $3.36B | 76.79% |
24,219,338
-764,087
| -3% | -$105M |
2013 Q2
16 quarters
|
|
|
2
iShares Core S&P 500 ETF
IVV
$847B
| $231M | 5.27% |
947,943
+218,804
| +30% | +$52.8M |
2013 Q2
16 quarters
|
|
|
3
iShares Core S&P Mid-Cap ETF
IJH
$121B
| $50.2M | 1.15% |
1,442,850
+368,695
| +34% | +$12.7M |
2013 Q2
16 quarters
|
|
|
4
iShares Core S&P Small-Cap ETF
IJR
$103B
| $42.2M | 0.96% |
601,916
+157,426
| +35% | +$10.9M |
2013 Q2
16 quarters
|
|
5
Apple
AAPL
$4.98T
| $18M | 0.41% |
500,080
-21,020
| -4% | -$777K |
2013 Q2
16 quarters
|
|
6
iShares S&P 500 Growth ETF
IVW
$72.1B
| $16.2M | 0.37% |
474,504
+13,980
| +3% | +$474K |
2013 Q2
16 quarters
|
|
7
iShares S&P 500 Value ETF
IVE
$49.9B
| $14M | 0.32% |
133,268
+198
| +0.1% | +$20.6K |
2013 Q2
16 quarters
|
|
8
iShares MSCI EAFE ETF
EFA
$75.6B
| $13.8M | 0.31% |
211,580
-2,482
| -1% | -$161K |
2013 Q2
16 quarters
|
|
9
Chubb
CB
$139B
| $13.7M | 0.31% |
94,192
-8,778
| -9% | -$1.24M |
2013 Q2
16 quarters
|
|
10
State Street Energy Select Sector SPDR ETF
XLE
$40.6B
| $13.6M | 0.31% |
419,242
-21,184
| -5% | -$712K |
2015 Q4
6 quarters
|
|
11
PepsiCo
PEP
$193B
| $13.3M | 0.3% |
115,343
-10,418
| -8% | -$1.2M |
2013 Q2
16 quarters
|
|
12
Alphabet (Google) Class C
GOOG
$3.49T
| $13.2M | 0.3% |
291,540
-15,560
| -5% | -$712K |
2013 Q2
16 quarters
|
|
|
CELG
13
DELISTED
Celgene Corp
CELG
| $12.2M | 0.28% |
94,134
-6,172
| -6% | -$756K |
2013 Q2
16 quarters
|
|
14
iShares MSCI Emerging Markets ETF
EEM
$27.5B
| $11.1M | 0.25% |
267,333
-5,599
| -2% | -$228K |
2015 Q3
7 quarters
|
|
15
Sherwin-Williams
SHW
$83.1B
| $10.9M | 0.25% |
92,799
-7,725
| -8% | -$863K |
2015 Q2
8 quarters
|
|
16
Honeywell
HON
$69.7B
| $10.8M | 0.25% |
89,356
-9,164
| -9% | -$1.08M |
2013 Q2
16 quarters
|
|
17
Visa
V
$790B
| $10.7M | 0.24% |
114,360
-2,677
| -2% | -$248K |
2013 Q2
16 quarters
|
|
18
iShares MSCI EAFE Value ETF
EFV
$15.1B
| $10.2M | 0.23% |
395,712
-11,820
| -3% | -$306K |
2014 Q2
12 quarters
|
|
19
3M
MMM
$95.5B
| $9.9M | 0.23% |
56,773
-1,405
| -2% | -$235K |
2013 Q2
16 quarters
|
|
20
NextEra Energy
NEE
$182B
| $9.8M | 0.22% |
278,540
-32,192
| -10% | -$1.1M |
2013 Q2
16 quarters
|
|
21
Verizon
VZ
$189B
| $9.42M | 0.21% |
210,815
-16,052
| -7% | -$748K |
2013 Q2
16 quarters
|
|
22
Lockheed Martin
LMT
$131B
| $9.3M | 0.21% |
33,481
-3,201
| -9% | -$879K |
2016 Q1
5 quarters
|
|
23
Starbucks
SBUX
$120B
| $9M | 0.21% |
154,332
-5,540
| -3% | -$335K |
2013 Q2
16 quarters
|
|
24
US Bancorp
USB
$92.6B
| $8.85M | 0.2% |
170,439
-16,829
| -9% | -$867K |
2015 Q4
6 quarters
|
|
25
Roper Technologies
ROP
$47.2B
| $8.66M | 0.2% |
37,386
-2,029
| -5% | -$449K |
2016 Q3
3 quarters
|
|
Similar funds
Greenleaf Trust's Q2 2017 Portfolio in Review
As of Q2 2017, Greenleaf Trust held 397 positions worth $4.38B, up 5.4% from $4.16B the previous quarter. Its ten largest holdings account for 86% of the portfolio.
Greenleaf Trust's Q2 2017 filing shows 76 new, 149 increased, 109 reduced and 25 closed positions. Its largest new stake was Steelcase: 402,630 shares worth $5.64M. The largest sale was Stryker, an estimated $105M.
By sector, the portfolio is most concentrated in Healthcare at 79% of assets, down from 81% a quarter earlier, followed by Miscellaneous and Financials.
- Greenleaf Trust's largest Q2 2017 buy was Steelcase: 402,630 shares worth $5.64M.
- Greenleaf Trust added most to iShares Core S&P 500 ETF in Q2 2017, an estimated $52.8M increase.
- Greenleaf Trust's biggest Q2 2017 reduction was Stryker, cutting an estimated $105M.
- Greenleaf Trust fully exited Mead Johnson Nutrition Company in Q2 2017, selling an estimated $4.44M.
- Greenleaf Trust's ten largest holdings make up 86% of its $4.38B portfolio in Q2 2017.
- Greenleaf Trust opened 76 new positions and closed 25 in Q2 2017.
- Greenleaf Trust's portfolio value rose 5.4% quarter-over-quarter to $4.38B.
Based on Greenleaf Trust's 13F filing for Q2 2017, filed 24 Jul 2017.